Invitation to Roche’s Investor Event at ASCO 2026
2026-04-30
 The Roche Investor Relations team would like to invite you to an analyst and investor event on Tuesday, 2 June 2026, to highlight Roche's late stage oncology pipeline with a special focus on giredestrant, at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (May 29 - June 2, 2026). Meeting information: Date/Time (CDT) Tuesday, 2 June 2026 1:00 – 2:00pm Registration & light lunch 2:00 – 3:30pm Presentations & Q&A Venue Marriott Downtown Chicago 540 North Michigan Avenue 60611 Chicago map To register for the event, please follow this > link (passcode: ASCO2026) The slides will be available for download at 1:00pm CDT on the day of the event. > click here Alternatively you may participate virtually in the webinar (access to speakers, pre-registration required). Please pre-register for the webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com . A replay of the event will be available via > ir.roche.com *privacy notice Best regards, | |
| Bruno Eschli Head of Investor Relations | Rafal Pawlowski Investor Relations Officer |
| Roche Investor Relations | |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Investors
Investor updates
stay updated
get the latest news and updates to your inbox.